Description
The World’s First Point-of-care genetic test used to guide neonatal management in time critical setting and reduce the risk of aminoglycoside induced hearing loss (AIHL)
The World’s First Point-of-care genetic test used to guide neonatal management in time critical setting and reduce the risk of aminoglycoside induced hearing loss (AIHL)
There are no inquiries yet.
Reviews
There are no reviews yet.